Losartan Blood Pressure Medication Recall Expanded Over Cancer Concerns

Torrent Pharmaceuticals Limited has again expanded a recall of its blood pressure medication over concerns the tablets contain small amounts of a cancer-causing ingredient. The Food and Drug Administration (FDA) announced Torrent Pharmaceuticals Limited voluntarily expanded the recall to include additional lots of its Losartan Potassium Tablets USP and Losartan Potassium/hydrochlorothiazide tablets. It is used to treat hypertension, hypertensive patients with Left Ventricular Hypertrophy, and nephropathy in Type 2 diabetic patients. The ingredient detected in the tablets was identified as N-Methylnitrosobutyric acid (NMBA), a known animal and potential human carcinogen. The news marks the fifth time the company has expanded the recall.

 
Brother Wease

Brother Wease

Want to know more about Brother Wease? Get their official bio, social pages & articles on Radio 95.1! Read more

title

Content Goes Here